
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Machine-learning-assisted single-vessel analysis of nanoparticle permeability in tumour vasculatures
Mingsheng Zhu, Jie Zhuang, Zhe Li, et al.
Nature Nanotechnology (2023) Vol. 18, Iss. 6, pp. 657-666
Open Access | Times Cited: 71
Mingsheng Zhu, Jie Zhuang, Zhe Li, et al.
Nature Nanotechnology (2023) Vol. 18, Iss. 6, pp. 657-666
Open Access | Times Cited: 71
Showing 1-25 of 71 citing articles:
Smart nanoparticles for cancer therapy
Leming Sun, Hongmei Liu, Yanqi Ye, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 390
Leming Sun, Hongmei Liu, Yanqi Ye, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 390
Nanotechnology’s frontier in combatting infectious and inflammatory diseases: prevention and treatment
Yujing Huang, Xiaohan Guo, Yi Wu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 151
Yujing Huang, Xiaohan Guo, Yi Wu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 151
AI-enabled organoids: Construction, analysis, and application
Long Bai, Yan Wu, Guangfeng Li, et al.
Bioactive Materials (2023) Vol. 31, pp. 525-548
Open Access | Times Cited: 79
Long Bai, Yan Wu, Guangfeng Li, et al.
Bioactive Materials (2023) Vol. 31, pp. 525-548
Open Access | Times Cited: 79
Designing nanotheranostics with machine learning
Lang Rao, Yuan Yuan, Xi Shen, et al.
Nature Nanotechnology (2024)
Closed Access | Times Cited: 31
Lang Rao, Yuan Yuan, Xi Shen, et al.
Nature Nanotechnology (2024)
Closed Access | Times Cited: 31
Expanding the Horizons of Machine Learning in Nanomaterials to Chiral Nanostructures
Vera Kuznetsova, Áine Coogan, Dmitry Botov, et al.
Advanced Materials (2024) Vol. 36, Iss. 18
Open Access | Times Cited: 25
Vera Kuznetsova, Áine Coogan, Dmitry Botov, et al.
Advanced Materials (2024) Vol. 36, Iss. 18
Open Access | Times Cited: 25
Nanoparticle delivery to tumours: from EPR and ATR mechanisms to clinical impact
Anshuman Dasgupta, Alexandros Marios Sofias, Fabian Kießling, et al.
Nature Reviews Bioengineering (2024) Vol. 2, Iss. 9, pp. 714-716
Closed Access | Times Cited: 20
Anshuman Dasgupta, Alexandros Marios Sofias, Fabian Kießling, et al.
Nature Reviews Bioengineering (2024) Vol. 2, Iss. 9, pp. 714-716
Closed Access | Times Cited: 20
Transvascular transport of nanocarriers for tumor delivery
Xin Li, Yong Hu, Xingcai Zhang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 19
Xin Li, Yong Hu, Xingcai Zhang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 19
Applications of liposomes and lipid nanoparticles in cancer therapy: current advances and prospects
Zhe Cheng, Huichao Huang, Mingru Yin, et al.
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Zhe Cheng, Huichao Huang, Mingru Yin, et al.
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access | Times Cited: 5
AI-Driven Innovations in Smart Multifunctional Nanocarriers for Drug and Gene Delivery: A Mini-Review
H. Noury, Abbas Rahdar, Luiz Fernando Romanholo Ferreira, et al.
Critical Reviews in Oncology/Hematology (2025), pp. 104701-104701
Closed Access | Times Cited: 4
H. Noury, Abbas Rahdar, Luiz Fernando Romanholo Ferreira, et al.
Critical Reviews in Oncology/Hematology (2025), pp. 104701-104701
Closed Access | Times Cited: 4
Rational Design of Dual-Targeted Nanomedicines for Enhanced Vascular Permeability in Low-Permeability Tumors
Mingsheng Zhu, Qiqi Liu, Zhengbang Chen, et al.
ACS Nano (2025)
Closed Access | Times Cited: 3
Mingsheng Zhu, Qiqi Liu, Zhengbang Chen, et al.
ACS Nano (2025)
Closed Access | Times Cited: 3
Assembly of Genetically Engineered Ionizable Protein Nanocage-based Nanozymes for Intracellular Superoxide Scavenging
Qiqi Liu, Zhanxia Gao, Xiangyun Zhang, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 3
Qiqi Liu, Zhanxia Gao, Xiangyun Zhang, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 3
Nanomedicines Targeting Metabolic Pathways in the Tumor Microenvironment: Future Perspectives and the Role of AI
Shuai Fan, Wenyu Wang, Wieqi Che, et al.
Metabolites (2025) Vol. 15, Iss. 3, pp. 201-201
Open Access | Times Cited: 2
Shuai Fan, Wenyu Wang, Wieqi Che, et al.
Metabolites (2025) Vol. 15, Iss. 3, pp. 201-201
Open Access | Times Cited: 2
The pathways for nanoparticle transport across tumour endothelium
Jamie L. Y. Wu, Qin Ji, Colin Blackadar, et al.
Nature Nanotechnology (2025)
Closed Access | Times Cited: 2
Jamie L. Y. Wu, Qin Ji, Colin Blackadar, et al.
Nature Nanotechnology (2025)
Closed Access | Times Cited: 2
Converting Nanotoxicity Data to Information Using Artificial Intelligence and Simulation
Xiliang Yan, Tongtao Yue, David A. Winkler, et al.
Chemical Reviews (2023) Vol. 123, Iss. 13, pp. 8575-8637
Closed Access | Times Cited: 35
Xiliang Yan, Tongtao Yue, David A. Winkler, et al.
Chemical Reviews (2023) Vol. 123, Iss. 13, pp. 8575-8637
Closed Access | Times Cited: 35
‘Passive’ nanoparticles for organ-selective systemic delivery: design, mechanism and perspective
Liyi Fu, Yang Zhang, Ryan A. Farokhzad, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 21, pp. 7579-7601
Closed Access | Times Cited: 32
Liyi Fu, Yang Zhang, Ryan A. Farokhzad, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 21, pp. 7579-7601
Closed Access | Times Cited: 32
Does the surface charge of the nanoparticles drive nanoparticle–cell membrane interactions?
Sandor Balog, Mauro Sousa de Almeida, Patricia Taladriz‐Blanco, et al.
Current Opinion in Biotechnology (2024) Vol. 87, pp. 103128-103128
Closed Access | Times Cited: 9
Sandor Balog, Mauro Sousa de Almeida, Patricia Taladriz‐Blanco, et al.
Current Opinion in Biotechnology (2024) Vol. 87, pp. 103128-103128
Closed Access | Times Cited: 9
Rational strategies for improving the efficiency of design and discovery of nanomedicines
Xiaoting Shan, Ying Cai, Binyu Zhu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 9
Xiaoting Shan, Ying Cai, Binyu Zhu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 9
Learning lessons from nano-medicine to improve the design and performances of nano-agrochemicals
Vu Thanh Cong, J. Justin Gooding, Mélanie Kah
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Vu Thanh Cong, J. Justin Gooding, Mélanie Kah
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Machine learning enabled multiscale model for nanoparticle margination and physiology based pharmacokinetics
Sahil Kulkarni, Benjamin Lin, Ravi Radhakrishnan
Computers & Chemical Engineering (2025), pp. 109081-109081
Closed Access | Times Cited: 1
Sahil Kulkarni, Benjamin Lin, Ravi Radhakrishnan
Computers & Chemical Engineering (2025), pp. 109081-109081
Closed Access | Times Cited: 1
Landscape of small nucleic acid therapeutics: moving from the bench to the clinic as next-generation medicines
Mohan Liu, Yusi Wang, Yi-Bing Zhang, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Mohan Liu, Yusi Wang, Yi-Bing Zhang, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Design Considerations for Organ-Selective Nanoparticles
Min‐Jun Baek, Won Hur, Satoshi Kashiwagi, et al.
ACS Nano (2025)
Closed Access | Times Cited: 1
Min‐Jun Baek, Won Hur, Satoshi Kashiwagi, et al.
ACS Nano (2025)
Closed Access | Times Cited: 1
STING agonist-boosted mRNA immunization via intelligent design of nanovaccines for enhancing cancer immunotherapy
Lei Zhou, Wenzhe Yi, Zehong Zhang, et al.
National Science Review (2023) Vol. 10, Iss. 10
Open Access | Times Cited: 21
Lei Zhou, Wenzhe Yi, Zehong Zhang, et al.
National Science Review (2023) Vol. 10, Iss. 10
Open Access | Times Cited: 21
Applying artificial intelligence and computational modeling to nanomedicine
Sean Hamilton, Benjamin R. Kingston
Current Opinion in Biotechnology (2023) Vol. 85, pp. 103043-103043
Closed Access | Times Cited: 20
Sean Hamilton, Benjamin R. Kingston
Current Opinion in Biotechnology (2023) Vol. 85, pp. 103043-103043
Closed Access | Times Cited: 20
Exploiting Nanotechnology for Drug Delivery: Advancing the Anti-Cancer Effects of Autophagy-Modulating Compounds in Traditional Chinese Medicine
Zixian Liu, Tianming Lu, Ruoning Qian, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 2507-2528
Open Access | Times Cited: 7
Zixian Liu, Tianming Lu, Ruoning Qian, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 2507-2528
Open Access | Times Cited: 7
Self‐Assembly of Heterogeneous Ferritin Nanocages for Tumor Uptake and Penetration
Qiqi Liu, Chunyu Wang, Mingsheng Zhu, et al.
Advanced Science (2024) Vol. 11, Iss. 17
Open Access | Times Cited: 7
Qiqi Liu, Chunyu Wang, Mingsheng Zhu, et al.
Advanced Science (2024) Vol. 11, Iss. 17
Open Access | Times Cited: 7